The Analysis of Long-Term Results and Quality of Life in Patients with Massive Pulmonary Embolism in the Course of Treatment with Thrombolytic and Anticoagulant Drugs
Relevance Chronic post-embolic pulmonary hypertension (CPEPH) is a complication of pulmonary thromboembolism found almost in every 10th patient. A special risk group consists of patients with a moderately high risk of pulmonary embolism associated death according to stratification of the probability...
Main Author: | A. G. Pronin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
2019-11-01
|
Series: | Неотложная медицинская помощь |
Subjects: | |
Online Access: | https://www.jnmp.ru/jour/article/view/687 |
Similar Items
-
Value of thrombolytic therapy for submassive pulmonary embolism patients
by: Magda A Ahmed, et al.
Published: (2018-01-01) -
THROMBOLYTIC AND ANTICOAGULANT THERAPY FOR PULMONARY EMBOLISM: AN EFFECT ON PULMONARY PERFUSION (PART 2)
by: O. V. Nikitina, et al.
Published: (2018-07-01) -
Thrombolytic-plus-Anticoagulant Therapy versus Anticoagulant-Alone Therapy in Submassive Pulmonary Thromboembolism (TVASPE Study): A Randomized Clinical Trial
by: Maryam Taherkhani, et al.
Published: (2015-10-01) -
Safety and Effectiveness of Thrombolytic Therapy Compared with Standard Anticoagulation in Subjects with Submassive Pulmonary Embolism
by: Pınar Çimen, et al.
Published: (2019-05-01) -
Deciding on thrombolytic therapy in pulmonary embolism - is there room for lactate?
by: Obradović Dušanka, et al.
Published: (2018-01-01)